Pseudomyxoma peritonei differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Nima Nasiri (talk | contribs) No edit summary |
Nima Nasiri (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Pseudomyxoma peritonei}} | {{Pseudomyxoma peritonei}} | ||
{{CMG}}{{AE}}{Nnasiri}}{{PSD}} | {{CMG}}{{AE}}{{Nnasiri}}{{PSD}} | ||
==Overview== | ==Overview== |
Revision as of 21:09, 14 January 2019
Pseudomyxoma peritonei Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pseudomyxoma peritonei differential diagnosis On the Web |
American Roentgen Ray Society Images of Pseudomyxoma peritonei differential diagnosis |
Risk calculators and risk factors for Pseudomyxoma peritonei differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]Parminder Dhingra, M.D. [3]
Overview
Pseudomyxoma peritonei must be differentiated from peritoneal carcinomatosis without mucinous ascites, peritoneal sarcomatosis, and peritonitis.
Differential Diagnosis
Pseudomyxoma peritonei must be differentiated from:[1][2]
- Peritoneal carcinomatosis without mucinous ascites
- Peritoneal sarcomatosis
- Peritonitis
References
- ↑ Harmon RL, Sugarbaker PH (February 2005). "Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer". Int Semin Surg Oncol. 2 (1): 3. doi:10.1186/1477-7800-2-3. PMC 549516. PMID 15701175.
- ↑ Carr NJ, Bibeau F, Bradley RF, Dartigues P, Feakins RM, Geisinger KR, Gui X, Isaac S, Milione M, Misdraji J, Pai RK, Rodriguez-Justo M, Sobin LH, van Velthuysen MF, Yantiss RK (December 2017). "The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei". Histopathology. 71 (6): 847–858. doi:10.1111/his.13324. PMID 28746986.